Effect of fluconazole on phagocytic response of polymorphonuclear leukocytes in a rat model of acute sepsis

Mediators of Inflammation

Volumn 2005, Issue 1, 2005, Pages 9-15

  Khan, Haseeb Ahmad ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; LUMINOL; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; EVALUATION; INFLAMMATION; INOCULATION; MALE; MULTIPLE ORGAN FAILURE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERITONEAL CAVITY; PERITONEAL FLUID; PERITONITIS; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT; SEPSIS; SEPTIC SHOCK; SURVIVAL;

ANALYSIS OF VARIANCE; ANIMALS; ANTIFUNGAL AGENTS; CHEMILUMINESCENT MEASUREMENTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUCONAZOLE; LEUKOCYTE COUNT; MALE; NEUTROPHILS; PERITONITIS; PHAGOCYTOSIS; RATS; RATS, WISTAR; SEPSIS; SHOCK, SEPTIC;

RATTUS NORVEGICUS;

EID: 21744444827     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1155/MI.2005.9     Document Type: Article

References (54)

1. Bone RC, Grodzin CJ, Balk RA. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest. 1997;112(1):235-243.
2. Singer M. Management of multiple organ failure: guidelines but no hard-and-fast rules. J Antimicrob Chemother. 1998;41 (suppl A):103-112.
3. Ikeda S, Saito H, Fukatsu K, et al. Dietary restriction impairs neutrophil exudation by reducing CD11b/CD18 expression and chemokine production. Arch Surg. 2001;136(3):297-304.
4. Mercer-Jones MA, Heinzelmann M, Peyton JC, Wickel D, Cook M, Cheadle WG. Inhibition of neutrophil migration at the site of infection increases remote organ neutrophil sequestration and injury. Shock. 1997;8(3):193-199.
5. Lowell CA, Berton G. Resistance to endotoxic shock and reduced neutrophil migration in mice deficient for the Src-family kinases Hck and Fgr. Proc Natl Acad Sci USA. 1998;95(13):7580-7584.
6. Goris RJ, te Boekhorst TP, Nuytinck JK, Gimbrere JS. Multiple-organ failure. Generalized autodestructive inflammation? Arch Surg. 1985;120(10):1109-1115.
7. Carey PD, Jenkins JK, Byrne K, et al. Neutrophil short-lived oxidant production: enhancement following onset of sepsis-induced lung injury. Circ Shock. 1992;36(4):256-264.
8. Karima R, Matsumoto S, Higashi H, Matsushima K. The molecular pathogenesis of endotoxic shock and organ failure. Mol Med Today. 1999;5(3):123-132.
9. Wagner JG, Roth RA. Neutrophil migration during endotoxemia. J Leukoc Biol. 1999;66(1):10-24.
10. Workman ML. The immune system: your defensive partner and offensive foe. AACN Clin Issues Crit Care Nurs. 1993;4(3):453-470.
11. Jaeschke H, Smith CW. Mechanisms of neutrophil-induced parenchymal cell injury. J Leukoc Biol. 1997;61(6):647-653.
12. Clatworthy MR, Smith KG. FcgammaRIIb balances efficient pathogen clearance and the cytokine-mediated consequences of sepsis. J Exp Med. 2004;199(5):717-723.
13. Drummond DC, Wong CW, Whitman LM, McCormack JG. The effects of amphotericin B, fluconazole and miconazole on neutrophil and lymphocyte function in a guinea pig model. J Antimicrob Chemother. 1995;36(2):375-384.
14. Di Francesco P, Gaziano R, Casalinuovo IA, Palamara AT, Favalli C, Garaci E. Antifungal and immunoadjuvant properties of fluconazole in mice immunosuppressed with morphine. Chemotherapy. 1997;43(3):198-203.
15. Pascual A, Garcia I, Conejo C, Perea EJ. Uptake and intracellular activity of fluconazole in human polymorphonuclear leukocytes. Antimicrob Agents Chemother. 1993;37(2):187-190.
16. Tariq M, Moutaery AA, Arshaduddin M, Khan HA, Price Evans DA, Jacobs S. Fluconazole attenuates lung injury and mortality in a rat peritonitis model. Intensive CareMed. 2003;29(11):2043-2049.
17. Jacobs S, Price Evans DA, Tariq M, Al Omar NF. Fluconazole improves survival in septic shock: a randomized double-blind prospective study. Crit Care Med. 2003;31(7):1938-1946.
18. Zervos EE, Bass SS, Robson MC, Rosemurgy AS. Fluconazole increases bactericidal activity of neutrophils. J Trauma. 1996;41(1):10-14.
19. Tullio V, Cuffini AM, De Leo C, Perrone F, Carlone NA. Interaction of Candida albicans, macrophages and fluconazole: in vitro and ex vivo observations. J Chemother. 1996;8(6):438-444.
20. Baldauf C, Adam D. Influence of fluconazole on phagocytosis, oxidative burst and killing activity of human phagocytes. Using a flow cytometric method with whole blood. Eur J Med Res. 2000;5(10):455-459.
21. Velert MM, Cabrera E, Orero A, Peman J, Canton E. Effect of fluconazole and itraconazole on human polymorphonuclear leukocyte oxidative metabolism and phagocytosis. Rev Esp Quimioter. 1998;11(1):70-74.
22. Odds FC, Webster CE. Effects of azole antifungals in vitro on host/parasite interactions relevant to Candida infections. J Antimicrob Chemother. 1988;22(4):473-481.
23. Vuddhakul V, Mai GT, McCormack JG, Seow WK, Thong YH. Suppression of neutrophil and lymphoproliferative responses in vitro by itraconazole but not fluconazole. Int J Immunopharmacol. 1990;12(6):639-645.
24. Roilides E, Walsh TJ, Rubin M, Venzon D, Pizzo PA. Effects of antifungal agents on the function of human neutrophils in vitro. Antimicrob Agents Chemother. 1990;34(2):196-201.
25. Abruzzo GK, Fromtling RA, Turnbull TA, Giltinan DM. Effects of bifonazole, fluconazole, itraconazole, and terbinafine on the chemiluminescence response of immune cells. J Antimicrob Chemother. 1987;20(1):61-68.
26. Noronha-Blob L, Lowe VC, Otterbein L, Steranka L, Burch RM. NPC 15669 reduces mortality associated with sepsis in rats. J Pharmacol Exp Ther. 1993;2(267):664-669.
27. Lilius EM, Waris MA. Very sensitive and rapid chemiluminescence method for the measurement of phagocytosis. In: Kricka RC, Stanley PE, Thorpe GH, et al, eds. Analytical Applications of Bioluminescence and Chemiluminescence. Orlando, Fla: Academic Press; 1984:401-404.
28. Khan HA. Zymosan-induced luminol-dependent chemiluminescence response of circulating and extravasated leukocytes in experimental sepsis. Mediators Inflamm. 2004;13(2):123-125.
29. Mercer-Jones MA, Shrotri MS, Heinzelmann M, Peyton JC, Cheadle WG. Regulation of early peritoneal neutrophil migration by macrophage inflammatory protein-2 and mast cells in experimental peritonitis. J Leukoc Biol. 1999;65(2):249-255.
30. Frode TS, Ferreira SI, Medeiros YS. Analysis of local and systemic inflammatory responses induced by polymicrobial peritonitis in mice. Mediators Inflamm. 2001;10(5):237-243.
31. Dunn DL, Barke RA, Knight NB, Humphrey EW, Simmons RL. Role of resident macrophages, peripheral neutrophils, and translymphatic absorption in bacterial clearance from the peritoneal cavity. Infect Immun. 1985;49(2):257-264.
32. Forman HJ, Torres M. Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. Am J Respir Crit Care Med. 2002;166(12 pt 2):S4-S8.
33. Knight JA. Review: free radicals, antioxidants, and the immune system. Ann Clin Lab Sci. 2000;30(2):145-158.
34. Tauber AI, Babior BM. Neutrophil oxygen reduction: the enzymes and the products. Free Radic Biol Med. 1985;1:265-307.
35. McCall TB, Boughton-Smith NK, Palmer RM, Whittle BJ, Moncada S. Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with superoxide anion. Biochem J. 1989;261(1):293-296.
36. Brestel EP. Co-oxidation of luminol by hypochlorite and hydrogen peroxide implications for neutrophil chemiluminescence. Biochem Biophys Res Commun. 1985;126(1):482-488.
37. Radi RA, Rubbo H, Prodanov E. Comparison of the effects of superoxide dismutase and cytochrome c on luminol chemiluminescence produced by xanthine oxidase-catalyzed reactions. Biochim Biophys Acta. 1989;994(1):89-93.
38. Radi R, Cosgrove TP, Beckman JS, Freeman BA. Peroxynitrite-induced luminol chemiluminescence. Biochem J. 1993;290(pt 1):51-57.
39. Goya T, Morisaki T, Torisu M. Immunologic assessment of host defense impairment in patients with septic multiple organ failure: relationship between complement activation and changes in neutrophil function. Surgery. 1994;115(2):145-155.
40. Shen SC, Nakao A, Kishimoto W, et al. The ability of polymorphonuclear leukocytes to produce active oxygen in a model of peritonitis in rats. Surg Today. 1993;23(7):603-608.
41. Oettinger CW, D'Souza M, Milton GV. Targeting macrophages with microspheres containing cytokine-neutralizing antibodies prevents lethality in gram-negative peritonitis. J Interferon Cytokine Res. 1999;19(1):33-40.
42. Goode HF, Cowley HC, Walker BE, Howdle PD, Webster NR. Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med. 1995;23(4):646-651.
43. Galley HF, Howdle PD, Walker BE, Webster NR. The effects of intravenous antioxidants in patients with septic shock. Free Radic Biol Med. 1997;23(5):768-774.
44. Martins PS, Kallas EG, Neto MC, Dalboni MA, Blecher S, Salomao R. Upregulation of reactive oxygen species generation and phagocytosis, and increased apoptosis in human neutrophils during severe sepsis and septic shock. Shock. 2003;20(3):208-212.
45. Alonso de Vega JM, Diaz J, Serrano E, Carbonell LF. Oxidative stress in critically ill patients with systemic inflammatory response syndrome. Crit Care Med. 2002;30(8):1782-1786.
46. Yao YM, Redl H, Bahrami S, Schlag G. The inflammatory basis of trauma/shock-associated multiple organ failure. Inflamm Res. 1998;47(5):201-210.
47. Bellingan GJ, Caldwell H, Howie SE, Dransfield I, Haslett C. In vivo fate of the inflammatory macrophage during the resolution of inflammation: inflammatory macrophages do not die locally, but emigrate to the draining lymph nodes. J Immunol. 1996;157(6):2577-2585.
48. Demirbilek S, Ersoy MO, Demirbilek S, et al. Effects of polyenylphosphatidylcholine on cytokines, nitrite/nitrate levels, antioxidant activity and lipid peroxidation in rats with sepsis. Intensive Care Med. 2004;30(10):1974-1978.
49. Messaris E, Antonakis PT, Memos N, Chatzigianni E, Leandros E, Konstadoulakis MM. Deferoxamine administration in septic animals: improved survival and altered apoptotic gene expression. Int Immunopharmacol. 2004;4(3):455-459.
50. Paskaloglu K, Sener G, Kapucu C, Ayanoglu-Dulger G. Melatonin treatment protects against sepsis-induced functional and biochemical changes in rat ileum and urinary bladder. Life Sci. 2004;74(9):1093-1104.
51. Ritter C, Andrades ME, Reinke A, Menna-Barreto S, Moreira JC, Dal-Pizzol F. Treatment with N-acetylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis. Crit Care Med. 2004;32(2):342-349.
52. Villa P, Saccani A, Sica A, Ghezzi P. Glutathione protects mice from lethal sepsis by limiting inflammation and potentiating host defense. J Infect Dis. 2002;185(8):1115-1120.
53. Durant R, Klouche K, Delbosc S, et al. Superoxide anion overproduction in sepsis: effects of vitamin E and simvastatin. Shock. 2004;22(1):34-39.
54. Heller AR, Groth G, Heller SC, et al. N-acetylcysteine reduces respiratory burst but augments neutrophil phagocytosis in intensive care unit patients. Crit Care Med. 2001;29(2):272-276.